Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496. Review.

2.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
3.

Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.

5.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
7.

Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.

González CA, Rubio-Guerra AF, Pavía A, Redding FJ, Cervantes JL, Zacarías JL, Yza R, Carranza J, Fernández P, Morales E, Robles FJ, Leyva JL, Rodríguez L.

Clin Drug Investig. 2007;27(5):333-7.

PMID:
17451281
8.

Clinical use of ezetimibe.

Cheng AY, Leiter LA.

Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Review.

PMID:
14571302
9.

Ezetimibe.

Darkes MJ, Poole RM, Goa KL.

Am J Cardiovasc Drugs. 2003;3(1):67-76; discussion 77-8. Review.

PMID:
14727947
10.
11.

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group.

Am Heart J. 2004 Sep;148(3):447-55.

PMID:
15389231
12.

Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.

Gotto AM Jr, Farmer JA.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):664-72. Review.

PMID:
17122799
13.

Ezetimibe: a selective cholesterol absorption inhibitor.

Nutescu EA, Shapiro NL.

Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.

PMID:
14620392
14.

Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

Bissonnette S, Habib R, Sampalis F, Boukas S, Sampalis JS; Ezetrol Add-On Investigators.

Can J Cardiol. 2006 Oct;22(12):1035-44. Erratum in: Can J Cardiol. 2007 Feb;23(2):159.

15.

Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor.

Lipka LJ.

Cardiovasc Drug Rev. 2003 Winter;21(4):293-312. Review.

PMID:
14647533
16.

Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.

Elis A, Zhou R, Stein EA.

Am J Cardiol. 2011 Jul 15;108(2):223-6. doi: 10.1016/j.amjcard.2011.03.027. Epub 2011 May 3.

PMID:
21545982
17.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
18.

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

Curr Med Res Opin. 2007 Aug;23(8):2009-26.

PMID:
17659159
20.

Ezetimibe therapy for dyslipidemia: an update.

Katsiki N, Theocharidou E, Karagiannis A, Athyros VG, Mikhailidis DP.

Curr Pharm Des. 2013;19(17):3107-14. Review.

PMID:
23317398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk